Browsing byAuthorFazekas, B

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 25  next >
Issue DateTitleAuthor(s)
2020-10A Multicomponent Nonpharmacological Intervention to Prevent Delirium for Hospitalized People with Advanced Cancer: A Phase II Cluster Randomized Waitlist Controlled Trial (The PRESERVE Pilot Study).Hosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, S; Cumming, A; Caplan, GA; Chye, R; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Parr, C; Williams, S; Hauser, K; McArdle, S; Jacquier, K; Phillipson, C; Kuwahata, L; Kerfoot, J; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Green, A; Hunt, J; Attwood, R; Assen, T; Garcia, M; Wilcock, J; Agar, M
2021-01-28A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancerCurrow, DC; Glare, P; Louw, S; Martin, P; Clark, K; Fazekas, B; Agar, MR
2020-05A randomized, double-blind, crossover, dose ranging study to determine the optimal dose of oral opioid to treat breakthrough pain for patients with advanced cancer already established on regular opioids.Currow, DC; Clark, K; Louw, S; Fazekas, B; Greene, A; Sanderson, CR
2020-01Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).King, MT; Agar, M; Currow, DC; Hardy, J; Fazekas, B; McCaffrey, N
2012-10-01Can assessing caregiver needs and activating community networks improve caregiver-defined outcomes? A single-blind, quasi-experimental pilot study: Community facilitator pilotGreene, A; Aranda, S; Tieman, JJ; Fazekas, B; Currow, DC
2013-12-01Can the LANSS scale be used to classify pain in chronic cancer pain trials?Hardy, J; Quinn, S; Fazekas, B; Agar, M; Currow, D
2019-01-01Comparability of the Australian National Cancer Symptom Trials (CST) Group's Study Populations to National Referrals to Non-CST Specialist Palliative Care Services Participating in the Palliative Care Outcomes CollaborationMatsuoka, H; Allingham, S; Fazekas, B; Brown, L; Vandersman, Z; Clark, K; Agar, MR; Currow, DC
2020-03-01Controlled-Release Oxycodone vs. Placebo in the Treatment of Chronic Breathlessness—A Multisite Randomized Placebo Controlled TrialFerreira, DH; Louw, S; McCloud, P; Fazekas, B; McDonald, CF; Agar, MR; Clark, K; McCaffrey, N; Ekström, M; Currow, DC
2019-01-01Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer painMcCaffrey, N; Flint, T; Kaambwa, B; Fazekas, B; Rowett, D; Currow, DC; Hardy, J; Agar, MR; Quinn, S; Eckermann, S
2020-10Evaluation of the IMPACCT Rapid Program: A Cross-Sectional Survey of International Site Investigators.Hunt, J; Brown, L; Fazekas, B; Doogue, M; Rowett, D; Luckett, T; Morgan, D; Reed-Cox, K; Sheehan, C; Tuffin, P; Currow, DC
2019-09-01Harms From Haloperidol for Symptom Management in Palliative Care—a Post Hoc Pooled Analysis of Three Randomized Controlled Studies and Two Consecutive Cohort StudiesMatsuoka, H; Agar, M; Vandersman, Z; Good, P; Fazekas, B; Brown, L; Hardy, J; Weil, J; Currow, DC
2020-10-31Health-related quality of life in patients with inoperable malignant bowel obstruction: secondary outcome from a double-blind, parallel, placebo-controlled randomised trial of octreotide.McCaffrey, N; Asser, T; Fazekas, B; Muircroft, W; Agar, M; Clark, K; Eckermann, S; Lee, J; Joshi, R; Allcroft, P; Sheehan, C; Currow, DC
2016-04-01How Accurately Do Consecutive Cohort Audits Predict Phase III Multisite Clinical Trial Recruitment in Palliative Care?McCaffrey, N; Fazekas, B; Cutri, N; Currow, DC
2019-12-01Low agreement between mMRC rated by patients and clinicians: Implications for practiceEkström, M; Chang, S; Johnson, MJ; Fazekas, B; Kochovska, S; Huang, C; Currow, DC
2019-01-01Multicomponent non-pharmacological intervention to prevent delirium for hospitalised people with advanced cancer: Study protocol for a phase II cluster randomised controlled trialHosie, A; Phillips, J; Lam, L; Kochovska, S; Noble, B; Brassil, M; Kurrle, SE; Cumming, A; Caplan, GA; Chye, R; Le, B; Ely, EW; Lawlor, PG; Bush, SH; Davis, JM; Lovell, M; Brown, L; Fazekas, B; Cheah, SL; Edwards, L; Agar, M
2020No excess harms from sustained-release morphine: a randomised placebo-controlled trial in chronic breathlessness.Johnson, MJ; Sbizzera, I; Fairhurst, C; Fazekas, B; Agar, M; Ekstrom, M; Currow, DC
2019-04-01Oral dexamethasone in the management of cancer-related pain: A feasibility studyEastman, P; Currow, DC; Fazekas, B; Brown, L; Le, B
2011-01-01Palliative care clinical trials: how nurses are contributing to integrated, evidence-based careHosie, A; Fazekas, B; Shelby-James, T; Mills, E; Byfieldt, N; Margitanovic, V; Hunt, J; Phillips, J
2015-01-01Pharmacovigilance in hospice/palliative care: Net effect of gabapentin for neuropathic painSanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC
2016-09-01Pharmacovigilance in hospice/palliative care: Net effect of pregabalin for neuropathic painSanderson, C; Quinn, SJ; Agar, M; Chye, R; Clark, K; Doogue, M; Fazekas, B; Lee, J; Lovell, MR; Rowett, D; Spruyt, O; Currow, DC